Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (750) Invanz, Merck,
...the treatment of moderate to severe infections caused by common gram-positive and gram-negative aerobic and anaerobic bacteria. Included, are community-acquired pneumonia, intra-abdominal, skin, urinary tract, kidney and ...
View Page

2.  Newly Approved Drug Therapies (117) Zosyn (sterile piperacillin sodium/tazobactam sodium), Wyeth,
...enzymes. Because of its broad spectrum of bactericidal activity against gram-positive and gram-negative aerobic and anaerobic organisms, Zosyn is also indicated as monotherapy for intra-abdominal infections (specifically appendicitis ...
View Page

3.  Study Posting (4519) Trial #96097, Diabetes Mellitus, Type 1, Aurora, CO
...Exclusion Criteria: • insulin pump therapy; • oral, inhaled, or pre-mixed insulin; • 30 minutes of cardiovascular (aerobic) exercise 5 days of a 7-day week. • renal insufficiency • on a day shift schedule ...
View Page

4.  CenterWatch Clinical Research Profile (5307) Trial #2177, The Cooper Institute, Dallas, TX
...or bicycle • T1 internet access • Dedicated monitoring rooms for CRA’s Available on the Cooper Aerobics Center campus: • CT angiography • Stress and rest echocardiography • CLIA approved blood laboratory • Colonoscopy • EBT • Cardiac ...
View Page

5.  Newly Approved Drug Therapies (585) Synercid I.V., Rhone Poulenc Rorer,
...in patients with diabetes or peripheral vascular disease since these infections were assumed to include aerobic gram-negative and anaerobic organisms, no specimen for culture obtained, insufficient therapy, no test of ...
View Page

6.  Newly Approved Drug Therapies (527) Atridox, Atrix Laboratories,
...C. rectus, F. nucleatum, Bacteroides forsythus, and E. corrodens in subgingival plaque samples. Levels of aerobic and anaerobic bacteria were also reduced after treatment with ATRIDOX. The clinical significance of these ...
View Page